DAEWOONG PHARMACEUTICAL CO., LTD Overview
Company Headquarters: Gangnam-gu, Seoul, Republic of Korea
Founded: 1945
Workforce: ~ 1,600+
Company Working:
Daewoong Pharmaceutical Co., Ltd is a prominent player in the Korean pharmaceutical market with a market share of approximately USD 800 million in the domestic market. The company focuses on research & development of solutions related to gastrointestinal, cardiovascular, neuroscience & pain, and fibrotic disease, immuno-oncology, and autoimmune disease. It operates through business segments such as prescribed medicine and medical devices. It has a strong presence in the global pharmaceutical market and exports its products to countries such as Australia, Canada, EU 28 countries, Hong Kong, the Middle East, Philippines, South Africa, Taiwan, Thailand, Turkey, the US, and Vietnam.
Strategy
Daewoong Pharmaceutical Co., Ltd is a leader in the Korean pharmaceutical market in the prescription products segment. The company focuses on increasing its geographical boundaries through strategic agreements and partnerships. It also focuses on increasing investments in research and development. For instance, it increased its R&D investment from 2.79% (2015) to 11.12% in 2016. The company emphasizes on strengthening its distribution and has a skilled workforce. It covers more than 15,000 hospitals & clinics and academic institutes.



